# EDGAR Filing Document

**Accession Number:** 0001659617
**File Stem:** 0001437749-25-020611
**Filing Date:** 2025-6
**Character Count:** 1933
**Document Hash:** 1ccfb8b71f2ddd3e18ed51ce1edf0f4d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-020611.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001437749-25-020611

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250617

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Moleculin Biotech, Inc.
- **CENTRAL INDEX KEY:** 0001659617
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 474671997
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 5300 MEMORIAL DRIVE
- **STREET 2:** SUITE 950
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77007
- **BUSINESS PHONE:** 713-300-5160

**MAIL ADDRESS:**
- **STREET 1:** 5300 MEMORIAL DRIVE
- **STREET 2:** SUITE 950
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77007

**Moleculin Biotech, Inc.**

**5300 Memorial Drive, Suite 950**

**Houston, TX 77007**

June 17, 2025

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

**Attention: Daniel Crawford**

---

| | |
|:---|:---|
| **Re:** | **Moleculin Biotech, Inc.** |

---

**Registration Statement on Form S-1**<br>

**Registration No. 333-287727**<br>

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Moleculin Biotech, Inc., a Delaware corporation (the "Company"), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 9:00 A.M. (Eastern Time) on June 18, 2025, or as soon thereafter as possible on such date.

---

| | |
|:---|:---|
| Very truly yours,<br>**Moleculin Biotech, Inc.** | Very truly yours,<br>**Moleculin Biotech, Inc.** |
| By:  | /s/ Jonathan P. Foster |
|  | Name: Jonathan P. Foster  |
|  | Title: Chief Financial Officer  |

---